Santhera Pharmaceuticals
SANN.SW
#8095
Rank
HK$1.65 B
Marketcap
HK$131.66
Share price
0.27%
Change (1 day)
55.26%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -HK$291.11

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$98.19. In 2022 the company made an earnings per share (EPS) of -HK$98.19 an increase over its 2021 EPS that were of -HK$137.81.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-HK$98.19-28.75%
2021-HK$137.81-69.23%
2020-HK$447.89222.64%
2019-HK$138.82-77.65%
2018-HK$621.12-5.34%
2017-HK$656.1652.2%
2016-HK$431.10-593.67%
2015HK$87.33-165.72%
2014-HK$132.88-2.15%
2013-HK$135.79-81.35%
2012-HK$728.2115.64%
2011-HK$629.71145.81%
2010-HK$256.18-53.37%
2009-HK$549.40-152.24%
2008HK$1,052-270.36%
2007-HK$617.29-33.09%
2006-HK$922.56